Oncohema Key

Fig. 1.1 Hematopoietic system cancers: incidence and mortality in the aged 70 years and more vs. the less than 70 years ones by site and gender (proportion per 100). HL…

Fig. 16.1 Shows the distribution dose during radiotherapy of an old female patient who was diagnosed with pelvic lesion from high grade lymphoma and who was unable to support the…

Component Reason for assessment Elements for assessment Method of evaluation Function Functional status measures how independent a patient is and is a key factor for determining treatment success or failure…

High (emesis risk >90 % without antiemetics) Carmustine, BCNU Lomustine Cisplatin Mechlorethamine Cyclophosphamide (>1,500 mg/m2) Pentostatin Dacarbazine, DTIC Procarbazine Moderate (emesis risk 30–90 % without antiemetics) Azacytidine Doxorubicin Alemtuzumab Imatinib…

Points Age (years) ECOG performance status LDH/ULN Leukocytes (×109/L) 0 <50 0–1 <0.670 6,700 1 50–59 – 0.670–0.999 6,700–9,999 2 60–69 2–4 1.000–1.499 10,000–14,999 3 >69 – >1.499 >14,999 Risk…

Fig. 4.1 SEER relative survival rates for AML by age group, 1988–2008. SEER surveillance end epidemiology and end results. http://​seer.​cancer.​gov Fig. 4.2 SEER relative survival rates for AML by age…

Refractory cytopenias with unilineage dysplasia (RCUD)  Refractory anemia (RA)  Refractory neutropenia (RN)  Refractory thrombocytopenia (RT) Refractory anemia with ring sideroblasts (RARS, ≥15 % BM ringed sideroblasts) Refractory cytopenia with multilineage…

  NHANES III [1] Olmsted county [4] Biella [5] Chicago [6] Iron deficiency 16 % 15 % 16 % 25 % Anemia of Chronic Inflammation (ACI) 33.6 % 36 %…